Horizon Wealth Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Other funds holding ABBV
Horizon Wealth Management's ABBV Position: Q3 2026 in Review
Horizon Wealth Management increased its AbbVie (ABBV) stake by 1.8% in Q3 2026, buying an estimated $18.7K and bringing the position to 4,230 shares worth $1.11M. The position accounts for 0.14% of the portfolio, ranked #66.
Horizon Wealth Management first reported a position in ABBV in Q4 2021 and has held it in 20 quarters since. 4,281 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.
- Horizon Wealth Management held 4,230 shares of AbbVie worth $1.11M as of Q3 2026.
- Horizon Wealth Management bought 73 AbbVie shares in Q3 2026, an estimated $18.7K.
- AbbVie made up 0.14% of Horizon Wealth Management's portfolio in Q3 2026, its #66 holding.
- Horizon Wealth Management first reported a position in AbbVie in Q4 2021 and has held it in 20 quarters since.
- 4,281 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.
Based on Horizon Wealth Management's 13F filing for Q3 2026, filed 2 Nov 2026.